Genmab — Maj 2018
-
En anden udfordring kan være en generel aktienedtur. Der er masse af usikkerhed i markedet pt. Italien ser ikke godt ud. Og så nærmer vi os sommerperioden som historisk ikke er for god.
-
Så gik A/B fra netto køb til netto salg.
-
Markedet ryger på røven pga Italien...
-
-
Prøv med en anden browser. Du har et gratis klip pr. dag.
-
Kæmpe ros til dig Helge for dit gøren i dette indslag. Hun gør ellers hvad hun kan for at få dig til at udvise bekymring omkring GEN. Fornuftige ting du har videreformidlet
. -
-
Glimrende indslag Helge

-
Cool! Good find @Sukkeralf !
-
Tak gutter - og tak til Sukker.

-
"
First-in-human, open-label, dose-escalation trial with expansion cohorts to evaluate safety of GEN1029 in patients with malignant solid tumors".
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind